“A Randomized Study of Sofosbuvir Plus Ribavirin With and Without PEG Interferon Alpha 2b in Treatment of Hepatitis C Genotype 3 Infection: Real Life Data from a Tertiary Care Center”. International Journal of Biomedical and Advance Research, vol. 9, no. 3, Apr. 2018, pp. 91-95, https://doi.org/10.7439/ijbar.v9i3.4673.